DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY

ODA Programmes within MRC Clinical Trials Unit

Project disclaimer

Disclaimer: The data for this page has been produced from IATI data published by DEPARTMENT FOR SCIENCE, INNOVATION AND TECHNOLOGY. Please contact them (Show Email Address) if you have any questions about their data.

Description

Clinical Trials Unit Southampton - International reputation for making important scientific discoveries in the lab and translating them into successful clinical treatments. Through links across the University, the NHS and industry able to push the boundaries of medical research and address key healthcare issues. There are a number of programmes under the CT unit: 1) The Blood borne viruses programme is currently focussed on two blood borne viruses with enormous global burden, and long term health and economic impact. DAC countries currently supported are Kenya, Uganda, South Africa, Zimbabwe, Vietnam, Thailand, Morocco, Mozambique, Egypt and Ukraine. The outcomes of these trials and studies will promote economic development and welfare by reducing the burden placed on these countries by these blood borne viruses 2) Respiratory infection: The DAC countries supported from the COVID-19 and TB trials being conducted in the respiratory programme are: Zimbabwe, Uganda, Mozambique, Ethiopia, South Africa, Zambia, India and Vietnam 3) The Syndromics programme has two sub-themes, the “acutely sick child in Africa” and “serious bacterial infections and antimicrobial resistance”, both of which are addressing development challenges by developing and testing interventions to reduce mortality and morbidity in children and adults in LMIC through programmes of randomised controlled trials, and associated epidemiological studies addressing questions around management and treatment. DAC countries currently supported are Kenya, Uganda, Mozambique, Ghana, Malawi, South Africa, Zambia, Bangladesh, Vietnam, Thailand, India, Brazil, China. The outcomes of these trials and studies will promote economic development and welfare by reducing the burden placed on these countries by acute and infectious diseases, particularly loss of economic output in adult carers due to illness in their children

Objectives

Research and development activity contributing to the UK’s strategy to address key development challenges.

---

Location

The country, countries or regions that benefit from this Programme.

Developing countries, unspecified

Disclaimer: Country borders do not necessarily reflect the UK Government's official position.